Overactive Bladder Treatment Global Market Report 2024

Description

“Overactive Bladder Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on overactive bladder treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for overactive bladder treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The overactive bladder treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Diseases Type: Idiopathic Bladder Overactivity; Neurogenic Bladder Overactivity
2) By Therapy: Anticholinergics; Mirabegron; Neurostimulation; Intravesical Instillation; Other Therapies
3) By Distribution Channel: Hospital Pharmacies; Drug Stores And Retail Pharmacies; Online Providers
Companies Mentioned: AbbVie Inc.; Astellas Pharma Inc.; Laborie Medical Technologies Corporation; Endo International plc; Hisamitsu Pharmaceutical Co. Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Overactive bladder encompasses a range of symptoms that can impact a person's frequency of urination and the sense of urgency. Treatment involves modifying specific behaviors, incorporating pelvic floor muscle exercises, and other measures aimed at alleviating symptoms. The objective of treatment is to effectively address the symptoms of an overactive bladder and decrease instances of urgent incontinence.

The primary categories of diseases in the treatment of overactive bladder are idiopathic bladder overactivity and neurogenic bladder overactivity. Idiopathic bladder overactivity involves an involuntary contraction of the bladder muscle, leading to a sudden and urgent urge to urinate. This condition is managed through overactive bladder (OAB) treatment methods, including anticholinergics and beta-3 agonists. Various therapies such as anticholinergics, mirabegron, neurostimulation, intravesical instillation, and other approaches are employed to treat these diseases. These therapies are available through channels such as hospital pharmacies, drug stores, retail pharmacies, and online providers.

The overactive bladder treatment market research report is one of a series of new reports from The Business Research Company that provides overactive bladder treatment market statistics, including overactive bladder treatment industry global market size, regional shares, competitors with an overactive bladder treatment market share, detailed overactive bladder treatment market segments, market trends and opportunities, and any further data you may need to thrive in the overactive bladder treatment industry. This overactive bladder treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The overactive bladder treatment market size has grown steadily in recent years. It will grow from $3.01 billion in 2023 to $3.13 billion in 2024 at a compound annual growth rate (CAGR) of 3.8%. The growth observed during the historical period can be ascribed to advancements in medication, increased patient awareness, demographic changes, adherence to clinical guidelines, and substantial investments in research.

The overactive bladder treatment market size is expected to see steady growth in the next few years. It will grow to $3.7 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%. The anticipated growth in the forecast period can be linked to factors such as an aging population, the development of advanced therapies, the implementation of personalized medicine, increased healthcare investments, and a focus on patient-centric care. Key trends expected during this period encompass non-pharmacological interventions, the adoption of digital health solutions, growing acceptance of alternative medicine, the incorporation of gender-specific approaches, and an emphasis on holistic care.

The overactive bladder treatment market is poised for growth, driven by the increasing elderly population. With the geriatric demographic, encompassing individuals aged 65 and older, being more susceptible to urinary tract infections due to factors such as diminished urine flow, overactive bladder, enlarged prostate, or kidney stones, there is a heightened demand for treatments targeting overactive bladder symptoms. As reported in July 2022 by ReliefWeb, the global population aged 65 and older is projected to rise from 10% in 2022 to 16% in 2050, reaching 94 million individuals, constituting 23% of the total population by 2050. Thus, the expanding geriatric population is a key factor propelling the overactive bladder treatment market's growth.

The prevalence of bladder cancer is another significant driver for the growth of the overactive bladder treatment market. Bladder cancer, characterized by abnormal cell growth in the bladder, often manifests with symptoms of overactive bladder. Treating these symptoms is crucial for improving the quality of life for individuals with bladder cancer. According to the American Society of Clinical Oncology's estimation in March 2023, around 82,290 adults in the United States are anticipated to be diagnosed with bladder cancer, with approximately 16,710 deaths expected in 2023. This underscores the correlation between bladder cancer and the prevalence of overactive bladder, contributing to the market's growth.

A notable trend in the overactive bladder treatment market is the approval of new products. Leading companies in the market are investing in the development of advanced products that incorporate the latest technologies to maintain their market positions. For example, in April 2023, Avation Medical Inc., a US-based company specializing in advanced neuromodulation and digital health, received FDA clearance for The Vivally System. This non-invasive bladder control therapy device, along with its accompanying mobile application, is designed to treat individuals suffering from urge urinary incontinence and urine urgency linked to overactive bladder syndrome. The system combines an ankle-worn garment with an intelligent controller, delivering personalized neuromodulation energy to the tibial nerve.

Innovation in treatments is a key focus for major companies in the overactive bladder treatment market. One such innovation involves the development of adrenergic receptor agonists, which mimic the effects of natural neurotransmitters to bind to adrenergic receptors. For instance, in April 2021, Urovant Sciences Ltd., a US-based clinical-stage biopharmaceutical company, introduced GEMTESA (vibegron) 75 mg tablets. This oral, once-daily medication is designed to address overactive bladder symptoms in adults, gaining approval from the U.S. Food and Drug Administration (FDA) as the first in its class for treating overactive bladder. Common side effects include dry mouth, headache, and constipation.

In March 2021, Sumitovant Biopharma, a US-based biopharmaceutical company, acquired Urovant Sciences Ltd. for an undisclosed amount. This strategic move is expected to provide long-term capital for business objectives and emphasize Sumitovant's commitment to developing and commercializing innovative therapies for urologic conditions, including overactive bladder treatments.

Major companies operating in the overactive bladder treatment market report are AbbVie Inc., Astellas Pharma Inc., Laborie Medical Technologies Corporation, Endo International plc, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson Services Inc., Medtronic plc, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Limited, Cogentix Medical Inc., Dr. Reddy's Laboratories Ltd., Sumitomo Pharma Co. Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Limited, Merck & Co. Inc., Macleods Pharmaceuticals Ltd., Bayer AG, Boehringer Ingelheim International GmbH, Eli Lilly and Company, GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., Mesoblast Limited, Novartis International AG, Novo Nordisk A/S, Daiichi Sankyo Company ltd., Boston Scientific Corporation, Grunenthal GmbH, Mallinckrodt Pharmaceuticals, Collegium Pharmaceutical Inc

North America was the largest region in the overactive bladder treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the overactive bladder treatment market report during the forecast period. The regions covered in the overactive bladder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the overactive bladder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The overactive bladder treatment market consists of revenues earned by entities by providing treatments such as behavioral therapies, nerve stimulation, and percutaneous tibial nerve stimulation (PTNS). The market value includes the value of related goods sold by the service provider or included within the service offering. The overactive bladder treatment market also includes sales of medications used in providing overactive bladder treatment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11207

1. Executive Summary

2. Overactive Bladder Treatment Market Characteristics

3. Overactive Bladder Treatment Market Trends And Strategies

4. Overactive Bladder Treatment Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Overactive Bladder Treatment Market Size and Growth

5.1. Global Overactive Bladder Treatment Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Overactive Bladder Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Overactive Bladder Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Overactive Bladder Treatment Market Segmentation

6.1. Global Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Idiopathic Bladder Overactivity
Neurogenic Bladder Overactivity
6.2. Global Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Anticholinergics
Mirabegron
Neurostimulation
Intravesical Instillation
Other Therapies
6.3. Global Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Drug Stores And Retail Pharmacies
Online Providers

7. Overactive Bladder Treatment Market Regional And Country Analysis

7.1. Global Overactive Bladder Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Overactive Bladder Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Overactive Bladder Treatment Market

8.1. Asia-Pacific Overactive Bladder Treatment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Overactive Bladder Treatment Market

9.1. China Overactive Bladder Treatment Market Overview
9.2. China Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Overactive Bladder Treatment Market

10.1. India Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Overactive Bladder Treatment Market

11.1. Japan Overactive Bladder Treatment Market Overview
11.2. Japan Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Overactive Bladder Treatment Market

12.1. Australia Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Overactive Bladder Treatment Market

13.1. Indonesia Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Overactive Bladder Treatment Market

14.1. South Korea Overactive Bladder Treatment Market Overview
14.2. South Korea Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Overactive Bladder Treatment Market

15.1. Western Europe Overactive Bladder Treatment Market Overview
15.2. Western Europe Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Overactive Bladder Treatment Market

16.1. UK Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Overactive Bladder Treatment Market

17.1. Germany Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Overactive Bladder Treatment Market

18.1. France Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Overactive Bladder Treatment Market

19.1. Italy Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Overactive Bladder Treatment Market

20.1. Spain Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Overactive Bladder Treatment Market

21.1. Eastern Europe Overactive Bladder Treatment Market Overview
21.2. Eastern Europe Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Overactive Bladder Treatment Market

22.1. Russia Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Overactive Bladder Treatment Market

23.1. North America Overactive Bladder Treatment Market Overview
23.2. North America Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Overactive Bladder Treatment Market

24.1. USA Overactive Bladder Treatment Market Overview
24.2. USA Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Overactive Bladder Treatment Market

25.1. Canada Overactive Bladder Treatment Market Overview
25.2. Canada Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Overactive Bladder Treatment Market

26.1. South America Overactive Bladder Treatment Market Overview
26.2. South America Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Overactive Bladder Treatment Market

27.1. Brazil Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Overactive Bladder Treatment Market

28.1. Middle East Overactive Bladder Treatment Market Overview
28.2. Middle East Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Overactive Bladder Treatment Market

29.1. Africa Overactive Bladder Treatment Market Overview
29.2. Africa Overactive Bladder Treatment Market, Segmentation By Diseases Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Overactive Bladder Treatment Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Overactive Bladder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Overactive Bladder Treatment Market Competitive Landscape And Company Profiles

30.1. Overactive Bladder Treatment Market Competitive Landscape
30.2. Overactive Bladder Treatment Market Company Profiles
- 30.2.1. AbbVie Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Astellas Pharma Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Laborie Medical Technologies Corporation
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Endo International plc
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Hisamitsu Pharmaceutical Co. Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Overactive Bladder Treatment Market Competitive Benchmarking

32. Global Overactive Bladder Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Overactive Bladder Treatment Market

34. Overactive Bladder Treatment Market Future Outlook and Potential Analysis

34.1 Overactive Bladder Treatment Market In 2028 - Countries Offering Most New Opportunities
34.2 Overactive Bladder Treatment Market In 2028 - Segments Offering Most New Opportunities
34.3 Overactive Bladder Treatment Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer